ecrin-mdr-crcClinical2020Advanced colorectal cancer or stomach cancerAdvanced Colorectal Cancer Or Stomach CancerInterventionalhttps://newmdr.ecrin.org/Study/2699928China11ECRIN MDRRecruitingfalseA prospective, multi-center, single-arm, open phase Ib clinical study of safety, tolerability and preliminary efficacy of anlotinib combined with duvalizumab in patients with advanced gastric or colorectal cancer who have failed second-line treatmentInterventions: experimental group:Anlotinib combined with Duvalizumab Primary outcome(s): DLT Study Design: Single arm2020-11-152699928ChiCTR2000039730